Anti-N-methyl-d-aspartate receptor encephalitis preceded by meningitis lasting up to 60 days

J Neuroimmunol. 2023 Sep 15:382:578173. doi: 10.1016/j.jneuroim.2023.578173. Epub 2023 Aug 7.

Abstract

Long-lasting meningitis complicated by N-methyl-d-aspartate receptor (NMDAR) encephalitis has not been discussed widely in the literature. Herein, we present two cases of anti-NMDAR encephalitis preceded by meningitis. The patients had 60- and 22-day periods of preceding meningitis, which improved with intravenous methylprednisolone and plasmapheresis. No tumors were detected in either of the patients. Although meningitis preceding anti-NMDAR encephalitis is not rare, our patients, especially those who had it for a duration of 60 days, had longer durations of meningitis. This manuscript foregrounds that anti-NMDAR encephalitis might be included in the differential diagnosis of long-lasting meningitis.

Keywords: Anti-N-methyl-d-aspartate receptor encephalitis; Immunotherapy; Meningitis.

MeSH terms

  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / complications
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / diagnostic imaging
  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / therapy
  • Humans
  • Meningitis* / complications
  • Methylprednisolone / therapeutic use
  • Plasmapheresis
  • Receptors, N-Methyl-D-Aspartate

Substances

  • Methylprednisolone
  • Receptors, N-Methyl-D-Aspartate